Effect of vitamin D replacement on maternal and neonatal outcomes: a randomised controlled trial in pregnant women with hypovitaminosis D. A protocol

M Chakhtoura, A Nassar, A Arabi, C Cooper, N Harvey, Z Mahfoud, M Nabulsi, G El-Hajj Fuleihan, M Chakhtoura, A Nassar, A Arabi, C Cooper, N Harvey, Z Mahfoud, M Nabulsi, G El-Hajj Fuleihan

Abstract

Introduction: The vitamin D recommended doses during pregnancy differ between societies. The WHO guidelines do not recommend routine prenatal supplementation, but they underscore the fact that women with the lowest levels may benefit most. The effects of routine supplementation during pregnancy on maternal and neonatal clinical outcomes have not been investigated in the Middle East, where hypovitaminosis D is prevalent. Our hypothesis is that in Middle Eastern pregnant women, a vitamin D dose of 3000 IU/day is required to reach a desirable maternal 25-hydroxyvitamin D [25(OH)D] level, and to positively impact infant bone mineral content (BMC).

Methods and analysis: This is a multicentre blinded randomised controlled trial. Pregnant women presenting to the Obstetrics and Gynaecology clinics will be approached. Eligible women will be randomised to daily equivalent doses of cholecalciferol, 600 IU or 3000 IU, from 15 to 18 weeks gestation until delivery. Maternal 25(OH)D and chemistries will be assessed at study entry, during the third trimester and at delivery. Neonatal anthropometric variables and 25(OH)D level will be measured at birth, and bone and fat mass assessment by dual-energy X-ray absorptiometry scan at 1 month. A sample size of 280 pregnant women is needed to demonstrate a statistically significant difference in the proportion of women reaching a 25(OH)D level ≥ 50 nmol/L at delivery, and a difference in infant BMC of 6 (10)g, for a 90% power and a 2.5% level of significance. The proportions of women achieving a target 25(OH)D level will be compared between the two arms, using χ(2). An independent t test will be used to compare mean infant BMC between the two arms. The primary analysis is an intention-to-treat analysis of unadjusted results.

Ethics and dissemination: The protocol has been approved by the Institutional Review Board at the American University of Beirut-Lebanon (IM.GEHF.22). The trial results will be published in peer-reviewed medical journals and presented at scientific conferences.

Trial registration number: NCT02434380.

Keywords: Bone mineral density; Middle East; Neonate; Pregnancy; Vitamin D.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Trial flow chart. BMD, bone mineral density.

References

    1. Kovacs CS, Fuleihan Gel-H. Calcium and bone disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 2006;35:21–51. 10.1016/j.ecl.2005.09.004
    1. Kovacs CS. Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 2011;40:795–826. 10.1016/j.ecl.2011.08.002
    1. Parkes I, Schenker JG, Shufaro Y. Parathyroid and calcium metabolism disorders during pregnancy. Gynecol Endocrinol 2013;29:515–19. 10.3109/09513590.2012.754880
    1. Bouillon R, Van Assche FA, Van Baelen H et al. . Influence of the vitamin D-binding protein on the serum concentration of 1, 25-dihydroxyvitamin D3: significance of the free 1, 25-dihydroxyvitamin D3 concentration. J Clin Invest 1981;67:589 10.1172/JCI110072
    1. Van Hoof HJ, de Sévaux RG, van Baelen H et al. . Relationship between free and total 1, 25-dihydroxyvitamin D in conditions of modified binding. Eur J Endocrinol 2001;144:391–6. 10.1530/eje.0.1440391
    1. Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr 2008;87:1087S–91S.
    1. Kovacs CS. Maternal vitamin D deficiency: fetal and neonatal implications. Semin Fetal Neonatal Med 2013;18:129–35.
    1. Arabi A, El Rassi R, El-Hajj Fuleihan G. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 2010;6:550–61. 10.1038/nrendo.2010.146
    1. Nassar N, Halligan GH, Roberts CL et al. . Systematic review of first-trimester vitamin D normative levels and outcomes of pregnancy. Am J Obstet Gynecol 2011;205:208.e1–7. 10.1016/j.ajog.2011.03.058
    1. Sahu M, Bhatia V, Aggarwal A et al. . Vitamin D deficiency in rural girls and pregnant women despite abundant sunshine in northern India. Clin Endocrinol 2009;70:680–4. 10.1111/j.1365-2265.2008.03360.x
    1. Molla AM, Al Badawi M, Hammoud MS et al. . Vitamin D status of mothers and their neonates in Kuwait. Pediatr Int 2005;47:649–52. 10.1111/j.1442-200x.2005.02141.x
    1. Hossain N, Khanani R, Hussain-Kanani F et al. . High prevalence of vitamin D deficiency in Pakistani mothers and their newborns. Int J Gynaecol Obstet 2011;112:229–33. 10.1016/j.ijgo.2010.09.017
    1. Ergür AT, Berberoğlu M, Atasay B et al. . Vitamin D deficiency in Turkish mothers and their neonates and in women of reproductive age. J Clin Res Pediatr Endocrinol 2009;1:266 10.4274/jcrpe.v1i6.266
    1. Bassil D, Rahme M, Hoteit M et al. . Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol 2013;5:274 10.4161/derm.25111
    1. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010;121:297–300. 10.1016/j.jsbmb.2010.02.021
    1. Van Der Meer IM, Middelkoop BJ, Boeke AJ et al. . Prevalence of vitamin D deficiency among Turkish, Moroccan, Indian and sub-Sahara African populations in Europe and their countries of origin: an overview. Osteoporos Int 2011;22:1009–21. 10.1007/s00198-010-1279-1
    1. Van Der Meer IM, Karamali NS, Boeke AJ et al. . High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr 2006;84:350–3.
    1. Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int 2013;92:128–39. 10.1007/s00223-012-9607-4
    1. Aghajafari F, Nagulesapillai T, Ronksley PE et al. . Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013;346.
    1. Poel YH, Hummel P, Lips P et al. . Vitamin D and gestational diabetes: a systematic review and meta-analysis. Eur J Intern Med 2012;23:465–9. 10.1016/j.ejim.2012.01.007
    1. Wei SQ, Qi HP, Luo ZC et al. . Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2013;26:889–99. 10.3109/14767058.2013.765849
    1. Tabesh M, Salehi-Abargouei A, Tabesh M et al. . Maternal vitamin D status and risk of pre-eclampsia: a systematic review and meta-analysis. J Clin Endocrinol Metab 2013;98:3165–73. 10.1210/jc.2013-1257
    1. Thorne-Lyman A, Fawzi WW. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr Perinat Epidemiol 2012;26(Suppl 1):75–90. 10.1111/j.1365-3016.2012.01283.x
    1. Javaid MK, Crozier SR, Harvey NC et al. . Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006;367:36–43. 10.1016/S0140-6736(06)67922-1
    1. Harvey NC, Moon RJ, Sayer AA et al. , Southampton Women's Survey Study Group. Maternal antenatal vitamin D status and offspring muscle development: findings from the Southampton Women's Survey. J Clin Endocrinol Metab 2013;99:330–7. 10.1210/jc.2013-3241
    1. Martin R, Harvey NC, Crozier SR et al. . Placental calcium transporter (PMCA3) gene expression predicts intrauterine bone mineral accrual. Bone 2007;40:1203–8. 10.1016/j.bone.2006.12.060
    1. Cleal JK, Day PE, Simner CL et al. . Placental amino acid transport may be regulated by maternal vitamin D and vitamin D-binding protein: results from the Southampton Women's Survey. Br J Nutr 2015;113:1903–10. 10.1017/S0007114515001178
    1. Javaid MK, Lekamwasam S, Clark J et al. . Infant growth influences proximal femoral geometry in adulthood. J Bone Miner Res 2006;21:508–12. 10.1359/jbmr.051214
    1. Ross AC. The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr 2011;14:938–9. 10.1017/S1368980011000565
    1. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30. 10.1210/jc.2011-0385
    1. ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 495: vitamin D: screening and supplementation during pregnancy. Obstet Gynecol 2011;118:197 10.1097/AOG.0b013e318227f06b
    1. WHO Guideline. Vitamin D supplementation in pregnant women 2012. (accessed Nov 2015).
    1. De-Regil LM, Palacios C, Ansary A et al. . Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev 2012;2:CD008873 10.1002/14651858.CD008873.pub2
    1. NICE Guidelines. 2008. (accessed Nov 2015).
    1. Hollis BW, Johnson D, Hulsey TC et al. . Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011;26:2341–57. 10.1002/jbmr.463
    1. Cooper C, Harvey N, Bishop N et al. , MAVIDOS Study Group. Maternal Gestational Vitamin D Supplementation and Offspring Bone Mass: a Multicentre Randomised, Double-Blind, Placebo-Controlled Trial (MAVIDOS). Abstract Presented at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting; 9–12 October 2015; Seattle; 2015.
    1. Sablok A, Batra A, Thariani K et al. . Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome. Clin Endocrinol (Oxf) 2015;83:536–41. 10.1111/cen.12751
    1. Dawodu A, Saadi HF, Bekdache G et al. . Randomized controlled trial (RCT) of vitamin D supplementation in pregnancy in a population with endemic vitamin d deficiency. J Clin Endocrinol Metab 2013;98:2337–46. 10.1210/jc.2013-1154
    1. Sabet Z, Ghazi A, Tohidi M et al. . Vitamin D supplementation in pregnant Iranian women: effects on maternal and neonatal vitamin D and parathyroid hormone status. Acta Endocrinol 2012;8:59–66.
    1. Soheilykhah S, Mojibian M, Moghadam MJ et al. . The effect of different doses of vitamin D supplementation on insulin resistance during pregnancy. Gynecol Endocrinol 2013;29:396–9. 10.3109/09513590.2012.752456
    1. Shakiba M, Iranmanesh MR. Vitamin D requirement in pregnancy to prevent deficiency in neonates: a randomised trial. Singapore Med J 2013;54:285–8. 10.11622/smedj.2013110
    1. . (accessed Nov 2015).
    1. College of American Pathologists. (accessed Nov 2015).
    1. DEQAS. (accessed Nov 2015).
    1. World Bank definition of Middle East countries. (accessed Nov 2015).
    1. Skinner AM, Cieslak Z, MacWilliam L et al. . The measurement of knee-heel length in newborn infants using a simple vernier calipers. Acta Paediatr 1997;86:512–17. 10.1111/j.1651-2227.1997.tb08922.x
    1. Bender R, Lange S. Adjusting for multiple testing—when and how? J Clin Epidemiol 2001;54:343–9. 10.1016/S0895-4356(00)00314-0
    1. Online sample size calculation. (accessed Nov 2015).
    1. Heaney RP, Davies KM, Chen TC et al. . Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204–10.
    1. Little RJ, D'Agostino R, Cohen ML et al. . The prevention and treatment of missing data in clinical trials. N Engl J Med 2012;367:1355–60. 10.1056/NEJMsr1203730
    1. Duke Radition Safety. (accessed Nov 2015).
    1. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014;72:48–54. 10.1111/nure.12090

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe